| Financial Year |
March 31 2023 |
| Monetary Funds |
241,769,403.33 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
794,485,889.13 |
| Advances to Suppliers |
103,159,582.87 |
| Other Receivables |
2,052,451.87 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
201,481,116.36 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,702,119.50 |
| Total Current Assets |
1,354,330,563.06 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
73,946,122.65 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,770,986.18 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
14,891,058.69 |
| Deferred Income Tax Assets |
32,399,988.43 |
| Other Non-Current Assets |
22,104,399.27 |
| Sub-Total of Non-Current Assets |
152,800,687.54 |
| Total Assets |
1,507,131,250.60 |
| Short-Term Loans |
95,201,431.76 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
160,073,569.33 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
9,429,875.68 |
| Taxes Payable |
9,619,061.88 |
| Interest Payable |
140,709.79 |
| Dividend Payable |
-- |
| Other payables |
17,323,052.08 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
10,225,341.93 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
303,393,967.19 |
| Long-term Loans |
10,318,063.70 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
2,384,458.51 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
17,955,205.89 |
| Total Liabilities |
321,349,173.08 |
| Paid-In Capital(Or Share Stock) |
398,052,633.00 |
| Capital Surplus |
596,650,126.10 |
| Surplus Reserve |
32,049,520.85 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
156,771,979.04 |
| Minority Stockholder's Interest |
720,306.88 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,185,061,770.64 |
| Owner's Equity（Stockholder's Equity） |
1,185,782,077.52 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,507,131,250.60 |
